Know Cancer

or
forgot password

Dimethylsulphoxide-Supported Photodynamic Therapy of Basal Cell Carcinoma Combined With Curretage - A 6 Year Clinical and Histological Evaluation.


N/A
18 Years
N/A
Not Enrolling
Both
Carcinoma, Basal Cell

Thank you

Trial Information

Dimethylsulphoxide-Supported Photodynamic Therapy of Basal Cell Carcinoma Combined With Curretage - A 6 Year Clinical and Histological Evaluation.


Inclusion Criteria:



- histological verified bcc.

- one or two PDT treatments with treatment interval no longer than two weeks.

- lesion complete response three months after therapy.

Exclusion Criteria:

- pregnant.

- Gorlin's syndrome.

- morpheaform or pigmented bcc.

- histology older than one year.

- tumour infiltration more than four mm.

- previous PDT treated lesions.

Type of Study:

Observational

Study Design:

Additional Descriptors: Convenience Sample, Time Perspective: Longitudinal, Time Perspective: Prospective

Principal Investigator

Eidi Christensen, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

St. Olav University Hospital, Trondheim

Authority:

Norway: Norwegian Social Science Data Services

Study ID:

EC-002

NCT ID:

NCT00218829

Start Date:

September 1997

Completion Date:

Related Keywords:

  • Carcinoma, Basal Cell
  • Photodynamic treatment
  • Basal cell carcinoma
  • DMSO
  • Carcinoma
  • Carcinoma, Basal Cell

Name

Location